CCM
KERX

Consonance Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Consonance Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,229,455
Closed -$37.1M – 27
2017
Q3 		$37.1M Sell
5,229,455
-1,775,586
-25% -$12.6M 4.11% 11
2017
Q2 		$50.6M Buy
+7,005,041
New +$50.6M 5.97% 10